2SEVENTY BIO INC's ticker is and the CUSIP is 901384107. A total of 128 filers reported holding 2SEVENTY BIO INC in Q4 2021. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $94,006 | -61.3% | 23,981 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $242,688 | +37.9% | 23,981 | +38.9% | 0.00% | – |
| Q1 2023 | $176,042 | +18.2% | 17,259 | +7.7% | 0.00% | – |
| Q4 2022 | $148,909 | -6.9% | 16,029 | +71.2% | 0.00% | -100.0% |
| Q1 2022 | $160,000 | -27.6% | 9,364 | +13.2% | 0.00% | 0.0% |
| Q4 2021 | $221,000 | – | 8,275 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Newtyn Management, LLC | 465,294 | $11,925,000 | 3.17% |
| VIRGINIA RETIREMENT SYSTEMS ET Al | 13,165 | $337,419,000 | 2.30% |
| EcoR1 Capital, LLC | 1,917,063 | $49,134,000 | 1.57% |
| Birchview Capital, LP | 27,999 | $718,000 | 0.46% |
| Sessa Capital IM, L.P. | 342,002 | $8,766,000 | 0.43% |
| Parametrica Management Ltd | 14,766 | $379,000 | 0.38% |
| Bain Capital Life Sciences Investors, LLC | 179,393 | $4,598,000 | 0.36% |
| ARMISTICE CAPITAL, LLC | 856,000 | $21,939,000 | 0.36% |
| Virtus ETF Advisers LLC | 13,134 | $337,000 | 0.13% |
| CAAS CAPITAL MANAGEMENT LP | 202,118 | $5,180,000 | 0.13% |